trehalose has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beger, RD; Bowyer, JF; Chigurupati, S; Hanig, JP; Mann, D; Paule, MG; Raymick, J; Sarkar, S; Schmitt, T; Schmued, LC | 1 |
| Gu, JH; Guan, JJ; Hou, YS; Qin, ZH; Wu, F; Xu, HD; Zhen, XC | 1 |
| Casarejos, MJ; Cuervo, AM; García de Yébenes, J; Gómez, A; Mena, MA; Perucho, J; Rodríguez, L; Rodríguez-Navarro, JA; Solano, RM | 1 |
3 other study(ies) available for trehalose and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Encephalitis; Glial Fibrillary Acidic Protein; Glucose Transporter Type 1; Male; Mice; Mice, Inbred C57BL; Microglia; Molecular Chaperones; Nerve Tissue Proteins; Neuroprotective Agents; Parkinsonian Disorders; Trehalose; Tyrosine 3-Monooxygenase; Zonula Occludens-1 Protein | 2014 |
Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Autophagy; Lysosomes; Male; Parkinsonian Disorders; Pars Compacta; PC12 Cells; Random Allocation; Rats; Rats, Inbred Lew; Rotenone; Trehalose; Tyrosine 3-Monooxygenase | 2015 |
Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
Topics: Animals; Autophagy; Corpus Striatum; Dopamine; Genotype; Mesencephalon; Mice; Mice, Transgenic; Neurofibrillary Tangles; Neurons; Parkinsonian Disorders; Polymerase Chain Reaction; tau Proteins; Tauopathies; Trehalose; Ubiquitin-Protein Ligases | 2010 |